Baxter International (BAX)
(Delayed Data from NYSE)
$23.09 USD
+0.12 (0.52%)
Updated Oct 17, 2025 04:00 PM ET
After-Market: $22.76 -0.33 (-1.43%) 7:58 PM ET
4-Sell of 5 4
A Value F Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BAX 23.09 +0.12(0.52%)
Will BAX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for BAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BAX
BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
BAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for BAX
Peering Into Baxter International Inc's Recent Short Interest
Richard Pzena's Strategic Acquisition in Usana Health Sciences Inc
Richard Pzena's Strategic Reduction in TriMas Corp Holdings
Is BAX showing upside potential? Crossed Above 20 Day Moving Average shows up after climbing 0.97%
BAX forms Directional Movement Crossover Bullish on October 15